Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct Venipuncture
NCT02207205 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2018-04-04
Summary
1. Determine if there is any difference between the whole blood clotting time results obtained from blood drawn from indwelling catheters and direct venipuncture
2. Determine the intra-subject variability in both procedures
Conditions
- Healthy
Interventions
- DRUG
-
Blood drawn from indwelling catheters versus direct venipuncture
Evaluation of the source of blood samples on whole blood clotting time
Sponsors & Collaborators
-
Duke Clinical Research Institute
collaborator OTHER -
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.
lead INDUSTRY
Principal Investigators
-
Robert Noveck, MD · Duke Clinical Research Unit
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2014-05-31
- Completion
- 2014-06-30
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants
NCT06582563 ·Status: NOT_YET_RECRUITING
-
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
NCT05301348 ·Status: RECRUITING ·Phase: NA
-
Prophylactic Anticoagulation for Catheter-related Thrombosis
NCT04256525 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT
NCT03172910 ·Status: COMPLETED ·Phase: PHASE2
-
Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal
NCT03064035 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study
NCT01704053 ·Status: COMPLETED
-
Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation
NCT00621491 ·Status: COMPLETED ·Phase: NA
-
3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
NCT00365950 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood
NCT01375725 ·Status: COMPLETED
-
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study
NCT03292666 ·Status: COMPLETED
-
Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients
NCT04982055 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
NCT00005684 ·Status: COMPLETED
-
The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
NCT00216866 ·Status: COMPLETED ·Phase: PHASE2
-
Direct Oral Anticoagulants and Venous Thromboembolism
NCT02833987 ·Status: COMPLETED
-
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
NCT02078154 ·Status: TERMINATED
-
Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter
NCT06975969 ·Status: WITHDRAWN
-
LEAVE Safe With DOACs
NCT04068727 ·Status: COMPLETED ·Phase: NA
-
Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy
NCT01810237 ·Status: WITHDRAWN ·Phase: NA
-
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT02213978 ·Status: COMPLETED
-
Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382
NCT03347968 ·Status: COMPLETED ·Phase: PHASE1
-
Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism
NCT01264458 ·Status: COMPLETED
-
Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis
NCT05705076 ·Status: UNKNOWN ·Phase: NA
-
Anticoagulant Therapy During Pacemaker Implantation
NCT00479362 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin
NCT04794348 ·Status: WITHDRAWN ·Phase: PHASE2
-
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1
NCT02371044 ·Status: COMPLETED